Author: admin

  • Faraday X Unveils Two Groundbreaking Global-First Products Along with a Transformative Technology Architecture – the FX Super One EAI-MPV, the FF Super EAI F.A.C.E. System, and the FF EAI Embodied Intelligence AI Agent 6×4 Architecture – Faraday Future

    1. Faraday X Unveils Two Groundbreaking Global-First Products Along with a Transformative Technology Architecture – the FX Super One EAI-MPV, the FF Super EAI F.A.C.E. System, and the FF EAI Embodied Intelligence AI Agent 6×4 Architecture  Faraday Future
    2. Faraday Future’s New FX Super One Luxury Van Has a Funky F.A.C.E.  MotorTrend
    3. Faraday Future’s New Electric Minivan Smells Like Vaporware  Edmunds
    4. Faraday Future updates on new financing, receipt of Wells notice  MSN
    5. Faraday Future Secures $105 Million to Launch Affordable EV Model  AInvest

    Continue Reading

  • The Strad news – New professor of violin at the University of Music and Theatre Munich

    The Strad news – New professor of violin at the University of Music and Theatre Munich

    Read more news stories here

    The University of Music and Theatre Munich (HMTM) has appointed Sarah Christian as professor of violin. She will begin in the role on 1 October 2025. 

    From 2019 until this year, Christian also served as professor of violin at the State University of Music and the Performing Arts Stuttgart. She has been first concertmaster of the Oslo Philharmonic since 2024 and concertmaster at the Deutsche Kammerphilharmonie Bremen since 2013. 

    In a statement, Christian said of the appointment: 

    ’I’m really looking forward to working with the students. I want to be there for them and do my best. I want to encourage them to follow their own personal musical path and to dare to find their own voice and make it heard – especially in today’s society. And I hope to make a lot of chamber music together.’

    Christian studied with Igor Ozim at the University Mozarteum Salzburg and with Antje Weithaas at the Hanns Eisler School of Music Berlin, where she was also assistant professor from 2013 to 2016.

    She has won various awards including second prize, audience award and the Special Prize of the Munich Chamber Orchestra at the 2017 ARD International Music Competition, as well as other prizes at the Michael Hill International Violin Competition, International Johannes Brahms Competition Pörtschach and Felix Mendelssohn Bartholdy University Competition in Berlin. In 2008 she received the Yehudi Menuhin Medal and the Best String Player of the Year award at the University Mozarteum Salzburg.

    As a soloist, Christian has performed with the Camerata Salzburg, Auckland Philharmonia, Deutsche Kammerphilharmonie Bremen, Munich Chamber Orchestra,  Bavarian Radio Symphony Orchestra and at Carnegie Hall with the Bavarian State Orchestra.

    Christian also regularly performs as a chamber musician at festivals such as SPANNUNGEN: in Heimbach, the Schwetzingen SWR Festival, Schleswig-Holstein Music Festival and Mecklenburg-Vorpommern Festival. In Augsburg, she founded her own chamber music series alongside German cellist Maximilian Hornung. She also initiated the Franz Ensemble, with which she plays rarely performed works. Her first album with the ensemble won the Opus Klassik 2020 award.

    Best of Technique

    In The Best of Technique you’ll discover the top playing tips of the world’s leading string players and teachers. It’s packed full of exercises for students, plus examples from the standard repertoire to show you how to integrate the technique into your playing.

    Masterclass

    In the second volume of The Strad’s Masterclass series, soloists including James Ehnes, Jennifer Koh, Philippe Graffin, Daniel Hope and Arabella Steinbacher give their thoughts on some of the greatest works in the string repertoire. Each has annotated the sheet music with their own bowings, fingerings and comments.

    Calendars

    The Canada Council of the Arts’ Musical Instrument Bank is 40 years old in 2025. This year’s calendar celebrates some its treasures, including four instruments by Antonio Stradivari and priceless works by Montagnana, Gagliano, Pressenda and David Tecchler.

    Continue Reading

  • PM directs govt-level plan to make EVs accessible to public – RADIO PAKISTAN

    1. PM directs govt-level plan to make EVs accessible to public  RADIO PAKISTAN
    2. PM Shehbaz Sharif pushes for rapid electric vehicle adoption in the country  Ptv.com.pk
    3. Govt to provide free electric bikes to top students  The Express Tribune
    4. Call for affordability as NEV Policy unveiled  Dawn
    5. Pakistan Electric 2-Wheeler 2025. A New National Plan Announced to Sustain the Fast Growing Segment  Motorcycles Data

    Continue Reading

  • Androgen Excess? New Guidelines Shift Focus Beyond Just PCOS

    Androgen Excess? New Guidelines Shift Focus Beyond Just PCOS

    The Society for Endocrinology, a UK-based organization representing a global community of scientists and clinicians working with hormones, has published updated guidelines for diagnosing and managing androgen excess in women.

    The new recommendations provide a practical, evidence-based framework, emphasizing early identification and treatment tailored to the underlying etiology. Unlike some national protocols that focus primarily on polycystic ovary syndrome (PCOS) — the most common cause of hyperandrogenism — these guidelines cover a broader spectrum of causes, offering a more comprehensive clinical approach.

    Early detection remains crucial, as certain effects of androgen excess — such as voice deepening, clitoromegaly, and androgenic alopecia — may be irreversible if left untreated.

    The guidelines define total testosterone levels above 86 ng/dL or free testosterone levels above 3.2 ng/dL as suggestive of hyperandrogenism. They also highlighted the importance of using accurate and standardized testing methods, cautioning that both under- and overdiagnosis can result from laboratory variability.

    To improve diagnostic reliability, the Society for Endocrinology recommends liquid chromatography-tandem mass spectrometry (LC-MS/MS) over immunoassays, citing its superior specificity and sensitivity, particularly at the low hormone concentrations typically observed in women.

    Proper sample preparation is also critical. Recommendations include fasting for at least 8 hours, collecting blood samples in the early morning between days 3 and 5 of the menstrual cycle, and discontinuing hormonal contraceptives for 6 to 8 weeks prior to testing. Given the high variability between labs, Karen de Marca Seidel, MD, director of the Brazilian Society of Endocrinology and Metabolism, highlighted the importance of this preparation in an interview with Medscape’s Portuguese edition.

    Speaking to Medscape’s Portuguese edition, Elaine Frade, PhD, head of the Department of Female Endocrinology, Andrology, and Transgender Health at the Brazilian Society of Endocrinology and Metabolism, noted that while LC-MS/MS is the gold standard, its availability is still limited in many countries, including Brazil, due to high costs and limited insurance coverage. As a result, many laboratories only offer LC-MS/MS testing after a preliminary abnormal result on conventional immunoassays.

    Causes and Treatment

    “The etiological investigation should be prompt and accurate, as treatment depends on the underlying cause. Symptoms can also have a significant psychosocial impact and may, in some cases, leave permanent effects,” Frade said.

    Androgen excess in women may stem from a range of causes — most commonly ovarian or adrenal in origin, but also from exogenous androgen use or, more rarely, disorders of sexual development. Ovarian causes include PCOS, ovarian hyperthecosis, and androgen-secreting tumors. Adrenal causes include congenital adrenal hyperplasia and adrenal tumors.

    Given its high global prevalence, PCOS should be the initial diagnostic consideration. According to the widely accepted Rotterdam criteria, diagnosis requires at least two of the following: oligo- or anovulation, clinical or biochemical signs of hyperandrogenism, and polycystic ovarian morphology on ultrasound. Frade noted that many women with PCOS also present with overweight or obesity and varying degrees of insulin resistance.

    Treatment for PCOS generally involves both pharmacologic and lifestyle interventions. These may include combined oral contraceptives, weight reduction, and regular physical activity. In cases where symptoms persist, antiandrogens may be introduced. “The choice of contraceptive depends on the predominant symptoms and the patient’s individual response. A progestin can be selected based on its targeted effect,” Frade explained.

    Seidel noted that in Brazil, commonly used therapeutic agents include spironolactone, metformin, and cyproterone acetate. The latter, a synthetic progestin with antiandrogenic properties, is not widely available in all countries but remains an option in selected cases. 

    Ovarian hyperthecosis, characterized by diffuse hyperplasia of the theca cells leading to sustained androgen production, is more frequently diagnosed in postmenopausal women. In such cases, bilateral oophorectomy is often the preferred management. For younger patients, conservative treatment using oral contraceptives and antiandrogens may be a viable option.

    Androgen-secreting ovarian tumors should be considered in cases with abrupt symptom onset, rapid progression, and pronounced signs of virilization, such as increased muscle mass and voice deepening. In these patients, serum testosterone levels often exceed 5 nmol/L, and transvaginal ultrasound is warranted for further evaluation.

    Among adrenal causes, nonclassic congenital adrenal hyperplasia is particularly noteworthy. Estimated to affect approximately 1% of women, this genetic condition can present with subtle symptoms and minimal virilization. A thorough family history should be taken. Screening includes measuring 17-hydroxyprogesterone during the follicular phase, with adrenocorticotropic hormone stimulation testing in ambiguous cases. Low-dose glucocorticoid therapy is typically reserved for symptomatic women seeking pregnancy or those who do not respond adequately to hormonal contraceptives.

    Adrenal tumors that produce androgens usually lead to elevated dehydroepiandrosterone sulfate levels. Diagnostic workup should include imaging studies such as abdominal CT or MRI. Treatment is surgical, with mitotane or chemotherapy considered in malignant cases.

    Seidel acknowledged that diagnosis is not always straightforward. “In major hospitals or referral centers, comprehensive investigations are feasible. But in the private sector, the quality of the workup often depends on the physician’s expertise and the patient’s ability to access additional testing,” she said.

    When clinical findings do not align with classic etiologies of hyperandrogenism, exogenous androgen use must be considered — even if patients do not readily disclose it. According to Seidel, this may now be one of the most common, yet underrecognized, causes of androgen excess in women in Brazil. Potential sources include hormone implants containing testosterone or gestrinone, anabolic steroids used for aesthetic purposes, or off-label hormone replacement therapies during menopause.

    Due to limited regulation and scarce reliable information about these products, many patients are unaware they are being exposed to androgens. Seidel noted that many present with clinical signs of androgen excess without realizing they are taking androgens.

    In this context, Frade emphasized a critical point: “There is no minimum testosterone threshold below which hormone replacement is indicated in women.” She stressed that the concept of “female androgen deficiency” lacks strong scientific validation and should not be used to justify hormone supplementation.

    Frade also highlighted that managing hyperandrogenism can be complex. Treatment typically requires long-term follow-up, and patients may have unrealistic expectations regarding the reversal of physical signs. “It’s essential to establish a clear and realistic treatment plan from the start. Even with effective management of the underlying cause, some clinical manifestations may be permanent or show only limited improvement,” she said.

    This story was translated from Medscape’s Portuguese edition.

    Continue Reading

  • An Seyoung dispatches Chen Yufei to reach Japan Open semi-finals

    An Seyoung dispatches Chen Yufei to reach Japan Open semi-finals

    Badminton world number one An Seyoung produced a dominant display to defeat rival Chen Yufei of the Peoples Republic of China in straight games and book her spot in the semi-finals of the BWF Japan Open 2025 in Tokyo on Thursday (18 July).

    The Republic of South Korea star powered past the Tokyo 2020 Olympic champion 21-16, 21-9, reversing her quarter-final defeat to Chen at the Singapore Open last month.

    An controlled the tempo from the outset and never looked back, wrapping up the women’s singles quarter-final victory in just 43 minutes.

    This marks An’s seventh semi-final appearance of the season. She has already won six titles this year, including the prestigious All England Open, and is chasing her first Japan Open crown since 2022.

    The 22-year-old will face either Han Yue (China) or Gunji Riko (Japan) in the semi-final.

    The Japan Open is available to stream on Olympic Channel via Olympics.com and the Olympics app from the quarter-finals onwards (geographical restrictions apply).

    Continue Reading

  • Linkin Park’s new era divided fans, Mike Shinoda is undeterred

    Linkin Park’s new era divided fans, Mike Shinoda is undeterred


    KARACHI:

    After the death of Linkin Park’s lead vocalist, Chester Bennington in 2017, the band is finally ready to make a comeback. In conversation with The Guardian, singer-songwriter Mike Shinoda and vocalist Emily Armstrong discussed the band’s rebirth and the backlash they have dealt with.

    25 years since its formation, Linkin Park has become one of the biggest US rock bands of this millennium. Their debut Hybrid Theory was one of the best selling albums of 2001 and since then, the band has garnered a massive worldwide fanbase. While they have given us bangers such as Numb and In the End, Linkin Park has struggled with deciding the course of their music career after Bennington’s death. 

    After much experimentation, the originally six person group decided to add two more people to the mix. Armstrong joined as co-lead vocalist and Colin Brittain as the drummer. This addition to the band was made while navigating fan reaction to Bennington’s death and understanding what musical path the group wants to take in future. Shinoda, who founded Linkin Park at 19 years of age, described what prompted him to pick Armstrong for lead vocals and why it upset fans. 

    “There were people who lashed out at Emily and it was really because she wasn’t a guy.” Shinoda narrated, “(The fans) are used to Linkin Park being six guys and the voice of a guy leading this song. They were just so uncomfortable with what it was that they chose a ton of things to complain about.”

    Despite fan backlash, Shinoda was fully confident in Armstrong’s enthusiasm to carry their legacy forward. “There are a lot of people for whom it’s all about follower count. It’s a very greedy way to live. And these guys aren’t that way,” he said. The singer thinks that Armstrong, “Who had a sassy little sister energy around Shinoda – seemed like a natural fit.” when he met her in the studio in 2023, “Something clicked.”  

    Staging a comeback  

    Armstrong’s selection was made on the basis of trials held at the band’s studio.”I didn’t tell them this was part of a potential Linkin Park comeback,” Shinoda revealed,“things could get awkwardly vague. Two hours into the session, they’d be like, ‘Hey, can I ask you a question? What’s going on here? Who are we writing for?’ And we’d be like: ‘Yeah, we don’t know.’”

    Finally he came across Armstong and was impressed by her respectability and enthusiasm for the kind of music we asked her to play. She was simply, “Excited to write with Mike Shinoda”. 

     

    Armstrong was the frontwoman for Dead Sara, a bluesy LA punk band that never really made it big. When she first heard about Shinoda’s offer, she was in disbelief,“I’ve (previously) been in a band for 20 years and I could only dream of this kind of success,” the new lead shared. Being Bennington’s replacement, Armstrong was slightly under pressure, she recalled, “I was scared at the prospect of stepping into such big shoes. ‘Why do I think I can do this?’ I wondered, I told Shinoda that I didn’t want to ‘ruin’ Linkin Park. I was like ‘you guys are a legacy band – you guys are so important.’” 

    New horizons

    Despite her hesitation, Shinoda is eager to take his music forward. In honour of Bennington, he released Post Traumatic on June 15, 2018, which was an emotional solo album that detailed his journey of processing grief. He described the tours as, “I felt like I was coping well and I was able to get up in the morning and not think about it, and I was evolving from the terrible stuff that had happened.” 

    However, it soon became exhausting, “I would go to the show and spend 90 minutes with half the crowd crying. And I’m like, this is exhausting. You know how therapists see patients all day and help them, but then they need therapy themselves? That’s how I felt.”

     

    Having processed his band-member’s death, Shinoda decided to recruit musicians, work on new music and move forward. Their eighth studio album, FROM ZERO, came out on November 15 via Warner Records. The new album is similar to the band’s original music, with rock rap fusion, easy to catch melodies, loud guitar harbouring and angry lyrics. 

    Now that the rock band is complete again, Linkin Park is all set to tour the US from July 29. While fans still look for traces of Bennington in their work, the hype for new music has not died. “This tour and this album are one of our most successful of all time.” marveled Shinoda,“That, for me, is insane. That is way beyond my hopes and dreams for what this whole thing could be.” 

    Have something you want to add to the story? Share it in the comments below. 

     

    Continue Reading

  • Alnylam’s Amvuttra approved by MHRA to treat rare heart disease ATTR-CM

    Alnylam’s Amvuttra approved by MHRA to treat rare heart disease ATTR-CM

    Alnylam Pharmaceuticals’ Amvuttra (vutrisiran) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adults with transthyretin amyloid cardiomyopathy (ATTR-CM), a rare and potentially fatal disease of the heart muscle.

    The drug has been authorised to treat wild-type or hereditary ATTR-CM, which occurs when misfolded transthyretin (TTR) protein accumulates and causes irreversible cardiovascular damage and severe health complications.

    Wild-type ATTR-CM is associated with ageing and most commonly affects people aged over 50 years, while the hereditary form, which is passed down genetically, is more prevalent among people of African ancestry.

    The UK regulator’s decision was supported by results from the late-stage HELIOS-B study, in which Amvuttra was associated with significant reductions in mortality and cardiovascular events in ATTR-CM patients.

    Alnylam’s drug was also shown to preserve functional status and quality of life, and effects were found to be consistent across all patient subgroups, including those on a concomitant TTR stabiliser.

    HELIOS-B investigator, Marianna Fontana, said: “As a physician, it’s a privilege to see a treatment that showed the potential to significantly improve outcomes in clinical trials now becoming available in practice – offering a new option for people living with this rapidly progressive disease.”

    Given as a subcutaneous injection once every three months either by a healthcare professional or self-administered by patients, Amvuttra is designed to work with the body’s natural system to knock down TTR at its source, helping to slow the accumulation of amyloid deposits.

    The drug is already approved by the MHRA to treat hereditary TTR-mediated ATTR amyloidosis in adults with stage 1 or stage 2 polyneuropathy.

    Phil Davey, country manager, Alnylam Pharmaceuticals, UK and Ireland, said: “[This] announcement is a significant step forward for people living with ATTR-CM and a moment of immense pride for Alnylam.

    “Since 2023, [Amvuttra] has been available in the UK for ATTR amyloidosis patients with polyneuropathy symptoms, and this expanded indication enables us to address the needs of a much broader group of people living with the disease.”

    Davey added that the company will now focus on “working collaboratively to secure access for patients across the NHS, without delay”.


    Continue Reading

  • Microsoft Offers Free Windows 10 Security Updates for Those Who Don’t Want to Upgrade to Windows 11

    Microsoft Offers Free Windows 10 Security Updates for Those Who Don’t Want to Upgrade to Windows 11

    The Windows 10 era is almost at an end. Microsoft is ending support for Windows 10 and stopping security support in October. Initially, Microsoft was offering a one-year extended security update for $30, but we’ve got some good news: Microsoft has added a free option, allowing you to stick with Windows 10 for another year. However, in order to access it, you’ll need to use cloud backup and connect it with your OneDrive account. 

    The ability to get free updates on Windows 10 is a pretty big deal because it is still the most widely used Windows OS, accounting for just over 53% of installs as of May 2025. That leaves millions of people without security support in just a few months unless they upgrade. So the cloud backup option gives users a way out without costing them any money. 

    The only potential issue is OneDrive. Anyone with a Microsoft account gets up to 5GB of storage for free. However, as The Verge points out, some backups may exceed this limitation, requiring users to purchase a monthly or yearly plan. At $2 per month for 100GB of cloud storage, a year of OneDrive still costs less than the $30 for a year of additional security updates, but it may still cause frustration among some customers. 

    Windows 10 was released a decade ago, in July 2015.

    A screenshot of Microsoft's Extended Security Updates wizard

    Microsoft will be rolling out the ESU wizard in July 2025. 

    Microsoft

    How to get Windows 10 security updates for free

    Per Microsoft’s blog post, there are now three options for those who want to stay on Windows 10 and still receive security updates: 

    You will be presented with these options starting in July, which is when Microsoft plans to roll out the sign-up wizard for the Extended Security Updates program. Signing up for this option will guarantee updates until Oct. 13, 2026, although businesses will have the option to purchase up to three years of additional updates. So, this isn’t a long-term solution, but rather gives you more time to upgrade to Windows 11. 

    It’s been an uphill battle for Microsoft, as people have been reluctant to upgrade their existing hardware. There are myriad differences between the two operating systems, but Microsoft’s string of unpopular decisions along with Windows 11 compatibility issues have kept the prior generation OS around a lot longer than it normally would be.


    Continue Reading

  • Study links good stress management to a more positive personality

    Study links good stress management to a more positive personality

    Managing stress may not just calm nerves in the moment, it also appears to nudge a person’s personality toward the sunnier side and strengthen long‑term health. That insight comes from a long‑running study that tracked 2,022 Americans from middle age into their late sixties.

    Participants who learned to keep daily hassles from rattling them grew steadily more extroverted, agreeable, and open to new experiences.


    On the flip side, peers whose reactions worsened became quieter, less friendly, and wary of novelty, explains William Chopik, associate professor of psychology at Michigan State University, over the years.

    Calming small stress helps personality

    Researchers call the immediate surge of frustration, worry, or anger that follows a hassle stress reactivity.

    High reactivity heightens blood pressure, floods the brain with cortisol, and sets the stage for wear and tear known as allostatic load.

    Most people face at least one minor stressor, a traffic jam or sharp email, on more than 40 percent of days. How they interpret and dampen those moments predicts nightly mood, sleep quality, and, over years, physical health.

    Daily stress also acts like an invisible drill sergeant, rehearsing the nervous system to react the same way the next time unless conscious countermeasures interrupt the script. Coping skills, therefore, become habits just as rigid as any physical routine.

    The new study tests whether changing that habit loop can send ripples upward, influencing stable dispositions rather than simply reflecting them.

    Tracking stress and personality change

    The team mined the National Study of Daily Experiences, a project that collects eight‑day diary bursts roughly every decade.

    Volunteers noted whether they argued, raced deadlines, or juggled interruptions, and rated negative feelings each evening.

    By averaging those daily scores, the researchers built a personal stress‑reactivity profile for each wave, then examined how those scores rose or fell across nearly two decades.

    Crucially, the diaries sat alongside annual inventories of the Big Five personality traits, giving the analysts a rare chance to watch coping shifts and character shifts march forward together.

    Sophisticated multilevel structural equation models controlled for age, gender, and baseline personality, reducing the odds that preexisting differences, rather than changing stress skills, explained later trait trajectories.

    Stress reactions changed personality traits

    Across the cohort, reactivity dropped with age, but the pace varied. Adults who cut their emotional spikes the most showed a 4 percent boost in extroversion and a 3 percent rise in agreeableness, compared with peers whose coping stagnated.

    “These improvements trickled up to affect how your personality changed over time,” said Chopik.

    Extroversion and agreeableness both predict higher life satisfaction, a pattern confirmed in dozens of studies, including work that links sociable moments to larger daily happiness gains.

    Openness to experience, the third trait boosted by calmer coping, correlates with lifelong learning and cognitive flexibility, qualities that often buffer aging‑related decline, according to personality researchers.

    How stress reshapes the brain

    Stress hormones interact with brain circuits that govern emotion, planning, and reward. When surges repeat, synapses remodel, gradually making threat detection louder and flexible thinking quieter.

    Animal and human studies led by neuroendocrinologist Bruce McEwen show that reducing cortisol spikes can restore hippocampal volume and improve executive function, reinforcing healthier coping loops.

    Functional‑MRI work also finds that people with lower reactivity maintain stronger connectivity between the prefrontal cortex and amygdala, an architecture linked to smoother social interactions.

    Over years, that neural rewiring could ease engagement and curiosity, aligning with the trait shifts spotted in the Michigan State dataset.

    Simple ways to build stress resilience every day

    Mindfulness, even in brief smartphone‑based courses, cuts perceived stress and boosts daily social contact, according to a two‑week randomized trial in young adults.

    Other tactics, such as labeling feelings, reframing hassles as challenges, or taking ten‑minute walks, tap the same regulatory circuits without the need for formal training.

    Cognitive‑behavioral therapy teaches people to challenge stress-driven catastrophic thoughts, while biofeedback provides real‑time heart‑rate clues that guide slower breathing, both methods shown to shrink daily spikes and support personality development.

    “If people can find ways to regulate their emotions, that might accumulate and translate to changing their personalities,” added Chopik.

    Why personality change matters

    Shifts toward extroversion and agreeableness are not just socially pleasant; they predict lower loneliness, better teamwork, and even reduced cardiovascular risk.

    Meta‑analyses link openness to experience with healthier aging behaviors, from physical activity to medication adherence, giving the trait medical relevance.

    Public‑health economists estimate that boosting average agreeableness by a single point on standard scales could save billions in conflict‑related workplace costs each year, though precise figures remain contested.

    Recognizing personality as malleable counters fatalism and supports policies that fund stress management in schools, prisons, and elder‑care centers.

    Questions for future research

    The diary method captures only eight days per decade, leaving gaps where major life events could shape both stress and character.

    Broader samples that include younger adults and non‑US cultures would clarify just how universal the effects are.

    Scientists also want to test whether interventions that directly target reactivity, biofeedback, mindfulness, or structured exercise, speed up the desirable personality tilt.

    Genetic analyses could reveal whether certain variants make coping skills easier to learn, helping personalize resilience training.

    Longer follow‑ups could show whether stress-related gains plateau or cascade, echoing earlier work by Roberts and colleagues indicating that personality traits keep shifting well past retirement age.

    The study is published in Psychology and Aging.

    —–

    Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates. 

    Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.

    —–


    Continue Reading

  • Best tablet deal: Save $70 on an Amazon Fire Max 11 tablet

    Best tablet deal: Save $70 on an Amazon Fire Max 11 tablet

    SAVE $70: As of July 18, the Amazon Fire Max 11 tablet (refurbished) is down to $129.99 at Amazon — a 35% discount off its usual $199.99 price.


    For those who’ve been dying for the latest Fire tablet for streaming, reading, and gaming, Amazon has a sweet deal on the Fire Max 11 (if you don’t mind a refurbished model). As of July 18, you can grab a refurbished Amazon Fire Max 11 tablet for $129.99 — 35% off its standard list price of $199.99. According to price tracker camelcamelcamel, that’s the lowest price this tablet has dropped to in 2025.

    This Fire Max 11 model has been tested and certified to look and function like new and even comes with the same warranty as a brand-new device. 

    SEE ALSO:

    The best Android tablets in 2025

    With a whole $70 off the price tag, you’re getting a vibrant 11-inch display, a powerful octa-core processor, and 14 hours of battery life, making it a seriously capable all-around performer for the price.

    The 2000×1200 resolution screen is built for watching shows, reading ebooks, and casual gaming — and it’s certified for low blue light, so your eyes won’t take a hit after hours of use. The aluminium build with reinforced glass also aims to add to its premium feel and durability. Amazon even claims it’s three times tougher than the 10.9-inch iPad in drop tests.

    You’ll also get 64GB of storage (expandable up to 1TB via microSD), WiFi 6 support for speedy connections, and access to Alexa features like smart home control and Show Mode. 

    Mashable Deals

    You can easily download streaming services like Netflix to watch Stranger Things on the go, and be ready to watch the upcoming Wednesday Season 2 in style. Add on the optional keyboard and stylus (sold separately), and the Fire Max 11 starts to feel like a productivity tool, too.

    If you’d also like an extra Kindle for reading, you can still score a like-new Kindle Paperwhite for $53 off at Amazon as well.

    The best tech deals right now, hand-picked by Mashable’s team of experts

    Continue Reading